Eotaxin and the attraction of eosinophils to the asthmatic lung

<p>Abstract</p> <p>Eosinophilic leukocytes accumulate in high numbers in the lungs of asthmatic patients, and are believed to be important in the pathogenisis of asthma. A potent eosinophil chemoattractant is produced in the asthmatic lung. This small protein, the chemokine eotaxin, is synthesized by a number of different cell types, and is stimulated by interleukin-4 and interleukin-13, which are produced by T-helper (Th)2 lymphocytes. Low molecular weight compounds have been developed that can block the eotaxin receptor C-C chemokine receptor (CCR)3, and prevent stimulation by eotaxin. This provides the potential for orally available drugs that can prevent eosinophil recruitment into the lung and the associated damage and dysfunction.</p>

Abstract licence: CC BY-NC-ND

• Corrected

  Fibroblast-to-myofibroblast transition in bronchial asthma · 2018

• Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes · 2011

• Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing · 2010

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.